A nanopharmaceutical is, by definition:

Metal- and carbon-based formulations are associated with high carcinogenic potential

Since SARS-CoV-2 is a lipid-enveloped virus, only lipid-based formulations may be used for encapsulation of viral components.

May protease inhibitors, integrase inhibitors and entry inhibitors may be used in the treatment of COVID-19?

Do nucleic acid-based formulations have any applications on the field of detection of SARS-CoV-2 and treatment of COVID-19?

Leave a Reply